机译:Ephrin-B2控制VEGF诱导的血管生成和淋巴管生成
Vascular Development Laboratory, Cancer Research UK London Research Institute, London WC2A 3PX, UK;
Department of Tissue Morphogenesis, Max-Planck-Institute for Molecular Biomedicine, and Faculty of Medicine, University of Muenster, D-48149 Muenster, Germany;
Department of Tissue Morphogenesis, Max-Planck-Institute for Molecular Biomedicine, and Faculty of Medicine, University of Muenster, D-48149 Muenster, Germany;
Vascular Development Laboratory, Cancer Research UK London Research Institute, London WC2A 3PX, UK;
Department of Tissue Morphogenesis, Max-Planck-Institute for Molecular Biomedicine, and Faculty of Medicine, University of Muenster, D-48149 Muenster, Germany Departments of Physiology & Pharmacology and Biochemistry, School of Medical Sciences, University of Bristol, Bristol BS6 6BS, UK;
Vascular Development Laboratory, Cancer Research UK London Research Institute, London WC2A 3PX, UK;
Vascular Development Laboratory, Cancer Research UK London Research Institute, London WC2A 3PX, UK Department of Tissue Morphogenesis, Max-Planck-Institute for Molecular Biomedicine, and Faculty of Medicine, University of Muenster, D-48149 Muenster, Germany;
Centre de Biologie du Developpement, Universite de Toulouse, CNRS, CBD UMR 5547, F-31062 Toulouse cedex 9, France;
Theodor Kocher Institute, University of Berne, CH-3012 Bern, Switzerland;
Oncalis AG, Schlieren, Switzerland;
Oncalis AG, Schlieren, Switzerland;
Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215-5501, USA;
Cancer Research UK London Research Institute, Lymphatic Development Laboratory, London WC2A 3PX, UK;
Departments of Physiology & Pharmacology and Biochemistry, School of Medical Sciences, University of Bristol, Bristol BS6 6BS, UK;
Vascular Development Laboratory, Cancer Research UK London Research Institute, London WC2A 3PX, UK Department of Tissue Morphogenesis, Max-Planck-Institute for Molecular Biomedicine, and Faculty of Medicine, University of Muenster, D-48149 Muenster, Germany;
机译:RhoB通过调节VEZF1介导的转录来控制损伤后成人血管生成和淋巴血管生成的协调
机译:RhoB通过调节VEZF1介导的转录来控制损伤后成人血管生成和淋巴血管生成的协调
机译:ADAMTS13促进血管生成并调节VEGF诱导的血管生成
机译:肿瘤血管生成和淋巴管生成对肿瘤分子转移至淋巴结驻留免疫细胞的大小调控轮廓的影响。
机译:用于通过特异性整合素结合调节VEGF诱导的血管生成的生物材料
机译:Syntenin通过增加内皮细胞中的ephrin-B2功能来促进VEGF诱导的VEGFR2内吞和血管生成
机译:ephrin-B2控制血管生成和淋巴管生成